Aim: Antibody-drug conjugates (ADCs) are an emerging class of anti-cancer therapies, designed to specifically target cancer cells while minimizing impact on healthy tissues; howeve
Loading
Source
2 developments in the corpus
Latest
Everything in the corpus, newest first.
Aim: Antibody-drug conjugates (ADCs) are an emerging class of anti-cancer therapies, designed to specifically target cancer cells while minimizing impact on healthy tissues; howeve
SEP 1, 2026 · JOURNAL ARTICLE
Oral
A structured health-system evidence synthesis and policy mapping that identifies gaps and recommends system-level reforms, rather than testing an intervention or measuring clinical outcomes.